The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging
Open accessAbstract
While emerging evidence suggests that neuroinflammation plays a crucial role in Alzheimer's disease, the impact of the microglia response in Alzheimer's disease remains a matter of debate. We aimed to study microglial activation in early Alzheimer's disease and its impact on clinical progression using a second-generation 18-kDa translocator protein positron emission tomography radiotracer together with amyloid imaging using Pittsburgh compound B positron emission tomography. We enrolled 96 subjects, 64 patients with Alzheimer's disease and 32 controls, from the IMABio3 study, who had both (11)C-Pittsburgh compound B and (18)F-DPA-714 positron emission tomography imaging. Patients with Alzheimer's disease were classified as prodromal Alzheimer's disease (n = 38) and Alzheimer's disease dementia (n = 26). Translocator protein-binding was measured using a simple ratio method with cerebellar grey matter as reference tissue, taking into account regional atrophy. Images were analysed at the regional (volume of interest) and at the voxel level. Translocator protein genotyping allowed the classification of all subjects in high, mixed and low affinity binders. Thirty high+mixed affinity binders patients with Alzheimer's disease were dichotomized into slow decliners (n = 10) or fast decliners (n = 20) after 2 years of follow-up. All patients with Alzheimer's disease had an amyloid positive Pittsburgh compound B positron emission tomography. Among controls, eight had positive amyloid scans (n = 6 high+mixed affinity binders), defined as amyloidosis controls, and were analysed separately. By both volumes of interest and voxel-wise comparison, 18-kDa translocator protein-binding was higher in high affinity binders, mixed affinity binders and high+mixed affinity binders Alzheimer's disease groups compared to controls, especially at the prodromal stage, involving the temporo-parietal cortex. Translocator protein-binding was positively correlated with Mini-Mental State Examination scores and grey matter volume, as well as with Pittsburgh compound B binding. Amyloidosis controls displayed higher translocator protein-binding than controls, especially in the frontal cortex. We found higher translocator protein-binding in slow decliners than fast decliners, with no difference in Pittsburgh compound B binding. Microglial activation appears at the prodromal and possibly at the preclinical stage of Alzheimer's disease, and seems to play a protective role in the clinical progression of the disease at these early stages. The extent of microglial activation appears to differ between patients, and could explain the overlap in translocator protein binding values between patients with Alzheimer's disease and amyloidosis controls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aβ itself acts as a proinflammatory agent, activating many inflammatory components.”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the early stages of AD, initial microglial activation may serve a protective role (anti-neuroinflammatory), whereby it tries to clear the amyloid and release nerve growth factors. However, when Aβ or other toxic products over-accumulate, proinflammatory phenotypes are activated, which damage the neurons [26].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the brains of patients with AD exhibited evidence of sustained inflammation.”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“[18F]DPA-714 was extensively studied in preclinical and clinical models [58–61], as a biomarker of neuroinflammation in various human CNS disorders [58].”
From Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression (2022) · cites this paper as [58]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, early neuroinflammation has been shown to be an adaptive mechanism by microglia that protects against AD pathology by reducing the levels of Aβ and tau.118–120”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [120]
In the citing paper
“In vivo imaging shows that microglia activation precedes the onset of AD (100) and is paralleled by increased levels of inflammatory markers in the cerebrospinal fluid (101)”
From Microglia in Alzheimer's disease (2017) · cites this paper as [100]
In the citing paper
“in MCI, microglial activation was positively correlated with cognition and gray matter volume, suggesting that microglial activation plays a protective role in the early phase of clinically apparent disease (100).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [100]
In the citing paper
“Of relevance, PET studies have indicated increased microglia activation in the precuneus and parietal cortex in AD.47,48”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [48]
In the citing paper
“Another study that divided AD subjects into fast decliners and slow decliners measured a higher TSPO signal in the brains of slow decliners, consistent with a protective role for microglial activation even in stages of AD when dementia is evident (Hamelin et al., 2016).”
From Microglia in Alzheimer’s disease (2018) · cites this paper as Hamelin et al., 2016
In the citing paper
“This is consistent with the finding that early microglial activation in response to amyloid plaques, as assessed by in vivo microglial imaging studies, is correlated with increased grey matter volume and reduced rate of cognitive decline46,47.”
In the citing paper
“Methods to image microglia exist and are being used to test the effect of treatments on microglia205–210.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [209]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Self-citationIn-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Microglia: Scapegoat, saboteur, or something else?
Aguzzi, A., Barres, B. A., & Bennett, M. L. (2013) · Science · doi:10.1126/science.1227901 · Cited by 836
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Conversion of amyloid positive and negative MCI to AD over 3 years
Okello, A., Koivunen, J., Edison, P., Archer, H. A., Turkheimer, F., Någren, K., Bullock, R. M., Walker, Z., Kennedy, A. M., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b23564 · Cited by 537
Lopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., MELTZER, C. C., Schimmel, K., Tsopelas, N. D., DeKosky, S. T., et al. (2005) · PubMed · Cited by 536
Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 522
Mhm, N., Chakravarthi, S., Aung, T., Htoo, P. M., Shwe, W. H., Gupalo, S., Udayah, M. W., Singh, H., Kabir, M. S., Thangarajan, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157212 · Cited by 35
Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer’s Disease?
Ceyzériat, K., Tournier, B. B., Millet, P., Frisoni, G. B., Garibotto, V., & Zilli, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190984 · Cited by 31
Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01209-6 · Cited by 31
Alzheimer’s disease: The role of T lymphocytes in neuroinflammation and neurodegeneration
Asamu, M. O., Oladipo, O. O., Abayomi, O. A., & Adebayo, A. A. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148589 · Cited by 32
Fujinaga, M., Luo, R., Kumata, K., Zhang, Y., Hatori, A., Yamasaki, T., Xie, L., Mori, W., Kurihara, Y., Ogawa, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00374 · Cited by 30
Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?
Nitsch, L., Schneider, L. H., Zimmermann, J., & Müller, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.639353 · Cited by 27
Luu, T. G., & Kim, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112545 · Cited by 32
Translocator protein in the rise and fall of central nervous system neurons
Cheung, G., Lin, Y. C., & Papadopoulos, V. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1210205 · Cited by 33
Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 33
Gray matter changes related to microglial activation in Alzheimer's disease
Nicastro, N., Malpetti, M., Mak, E., Williams, G. B., Bevan-Jones, W. R., Carter, S. F., Passamonti, L., Fryer, T. D., Hong, Y. T., Aigbirhio, F. I., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.010 · Cited by 30
Wang, Q., Schindler, S. E., Chen, G., McKay, N. S., McCullough, A. A., Flores, S. E., Liu, J., Sun, Z., Wang, S., Wang, W., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000208013 · Cited by 27
Molecular imaging in the diagnosis of Alzheimer's disease and related disorders
Koric, L., Guedj, É., Habert, M., Semah, F., Branger, P., Payoux, P., & Jeune, F. L. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.10.009 · Cited by 29
Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29
Repeatability and Reproducibility of in-vivo Brain Temperature Measurements
Sharma, A. A., Nenert, R. E., Mueller, C., Maudsley, A. A., Younger, J., & Szaflarski, J. P. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.598435 · Cited by 27
Sheng, X., Yao, Y., Huang, R., Xu, Y., Zhu, Y., Chen, L., Zhang, L., Wang, W., Zhuo, R., Can, D., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02340-7 · Cited by 27
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Gouilly, D., Rafiq, M., Nogueira, L., Salabert, A., Payoux, P., Péran, P., & Pariente, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.006 · Cited by 31
Hou, Z., Sun, L., Jiang, Z., Zeng, T., Wu, P., Huang, J., Liu, H., & Xiao, P. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155374 · Cited by 30
Correlation of microglial activation with white matter changes in dementia with Lewy bodies
Nicastro, N., Mak, E., Williams, G. B., Surendranathan, A., Bevan-Jones, W. R., Passamonti, L., Rodríguez, P. V., Su, L., Arnold, R. J., Fryer, T. D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102200 · Cited by 29
Kuo, Y., & Rajesh, R. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1621750 · Cited by 27
Chronic pain in Alzheimer's disease: Endocannabinoid system
Blanton, H. L., Reddy, P. H., & Benamar, K. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114287 · Cited by 30
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Susmitha, G., & Kumar, R. K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109478 · Cited by 27
A Systematic Review of the Effects of Capsaicin on Alzheimer’s Disease
Inyang, D., Saumtally, T., Nnadi, C. N., Devi, S., & So, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210176 · Cited by 28
Iaccarino, L., Moresco, R. M., Presotto, L., Bugiani, O., Iannaccone, S., Giaccone, G., Tagliavini, F., & Perani, D. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0522-6 · Cited by 26
Wrzesień, A., Andrzejewski, K., Jampolska, M., & Kaczyńska, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042327 · Cited by 25
Beaurain, M., Salabert, A., Ribeiro, M. J., Arlicot, N., Damier, P., Jeune, F. L., Démonet, J., & Payoux, P. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00268 · Cited by 26
Knowledge gaps in Alzheimer's disease immune biomarker research
Morgan, D., & Mielke, M. M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12342 · Cited by 26
Hisaoka‐Nakashima, K., Ohata, K., Yoshimoto, N., Tokuda, S., Yoshii, N., Nakamura, Y., Wang, D., Liu, K., Wake, H., Yoshida, T., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114146 · Cited by 26
Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A. K., Jacobs, A. H., & IMBI Project (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.004 · Cited by 25
Daniilidou, M., Holleman, J., Hagman, G., Kåreholt, I., Aspö, M., Brinkmalm, A., Zetterberg, H., Blennow, K., Solomon, A., Kivipelto, M., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03072-x · Cited by 27
Pulagam, K. R., Colás, L., Padró, D., Plaza‐García, S., Gómez‐Vallejo, V., Higuchi, M., Llop, J., & Martín, A. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0343-7 · Cited by 24
Huang, R., Zhu, Z., Wu, Q., Bekhit, A. E.-D. A., Wu, S., Chen, M., Wang, J., & Ding, Y. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1975093 · Cited by 23
Stær, K., Iranzo, Á., Stokholm, M. G., Hvingelby, V. S., Danielsen, E. H., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., et al. (2024) · Movement Disorders · doi:10.1002/mds.29767 · Cited by 23
Affuso, F., Micillo, F., & Fazio, S. (2024) · Biomedicines · doi:10.3390/biomedicines12081888 · Cited by 25
IL-18 induced IL-23/IL-17 expression impairs Aβ clearance in cultured THP-1 and BV2 cells
Chen, J.-M., Li, Q., Jiang, G., Liu, J.-S., & Cheng, Q. H. (2019) · Cytokine · doi:10.1016/j.cyto.2019.03.003 · Cited by 23
Microglia in Alzheimer’s Disease
Süß, P., & Schlachetzki, J. C. M. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200212155234 · Cited by 26
Thomas, A. J., Hamilton, C. A., Donaghy, P. C., Martin-Ruiz, C. M., Morris, C. M., Barnett, N., Olsen, K., Taylor, J., & O'Brien, J. T. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5365 · Cited by 23
Microglia across evolution: from conserved origins to functional divergence
Shimizu, T., & Prinz, M. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01368-6 · Cited by 28
PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [18F]DPA714
Hu, W., Pan, D., Wang, Y., Bao, W., Zuo, C., Guan, Y., Hua, F., Yang, M., & Zhao, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00810 · Cited by 22
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 22
iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype
Sullivan, M. A., Lane, S. D., McKenzie, A. D. J., Ball, S. R., Sunde, M., Neely, G. G., Moreno, C. L., Maximova, A., Werry, E. L., & Kassiou, M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02951-2 · Cited by 23
Kovbasyuk, Z., Tefera, E., Li, C., Baete, S. H., & Steriade, C. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03598-x · Cited by 23
Microglia in brain aging: An overview of recent basic science and clinical research developments
Fan, H., Zhang, M., Wen, J., Wang, S., Yuan, M., Sun, H., Shu, L., Xu, Y., Pu, Y., & Cai, Z. (2023) · Journal of Biomedical Research · doi:10.7555/jbr.37.20220220 · Cited by 23
Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review
Loveland, P. M., Yu, J. J., Churilov, L. P., Yassi, N., & Watson, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512116 · Cited by 24
Miyajima, N., Ito, M., Rokugawa, T., Iimori, H., Momosaki, S., Omachi, S., Shimosegawa, E., Hatazawa, J., & Abe, K. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0400-x · Cited by 21
Su, Y., Li, H., Zhang, W., Tao, S., Wang, Q., Zhang, X., Zhou, M., Huang, X., Wang, C., Tang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60746-w · Cited by 28
PET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 20
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
Busch, L., Eggert, S., Endres, K., & Bufe, B. (2022) · Cells · doi:10.3390/cells11213421 · Cited by 20
Cheval, M., Rodrigo, S., Taussig, D., Caillé, F., Petrescu, A. M., Bottlaender, M., Tournier, N., Besson, F. L., Leroy, C., & Bouilleret, V. (2023) · Neurology · doi:10.1212/wnl.0000000000207811 · Cited by 20
Self-citationEndepols, H., Anglada‐Huguet, M., Mandelkow�, E., Schmidt, Y., Krapf, P., Zlatopolskiy, B. D., Neumaier, B., Mandelkow, E., & Drzezga, A. E. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02793-8 · Cited by 18
The genetic basis of multiple system atrophy
Tseng, F. S., Foo, J. Q. X., Mai, A. S., & Tan, E. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03905-1 · Cited by 26
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer’s Disease
Su, M., Nizamutdinov, D., Liu, H., & Huang, J. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119272 · Cited by 26
Current status of PET tracers for the early diagnosis of Alzheimer's disease
Li, Y., Liu, T., Zeng, Q., & Cui, M. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117546 · Cited by 20
Pizzirusso, G., Preka, E., Goikolea, J., Aguilar-Ruiz, C., Rodriguez‐Rodriguez, P., Vázquez-Cabrera, G., Laterza, S., Latorre‐Leal, M., Eroli, F., Blomgren, K., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.009 · Cited by 21
Yrondi, A., Aouizerate, B., El-Hage, W., Moliere, F., Thalamas, C., Delcourt, N., Sporer, M., Taib, S., Schmitt, L., Arlicot, N., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00326 · Cited by 19
Counil, H., & Krantic, S. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191237 · Cited by 20
Brain interleukins and Alzheimer’s disease
Abdelhamed, H. G., Hassan, A. A., Sakraan, A., Al-Deeb, R. T., Mousa, D. M., Ezz, H. S. A., Noor, N. A., Khadrawy, Y. A., & Radwan, N. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01538-5 · Cited by 20
Raj, A., Torok, J., & Ranasinghe, K. G. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102750 · Cited by 20
Novel Tracers and Radionuclides in PET Imaging
Mason, C. A., Gimblet, G. R., Lapi, S. E., & Lewis, J. S. (2021) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2021.05.012 · Cited by 19
Cai, M., Zhang, Y., Chen, S. X., Wu, Z., & Zhu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.968444 · Cited by 20
Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
Ibanez, K. R., McFarland, K. N., Phillips, J., Allen, M., Lessard, C. B., Zobel, L., De La Cruz, E. G., Shah, S., Vo, Q., Wang, X., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01044-1 · Cited by 18
Cheon, J., Kwon, S.-Y., & Kim, M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14432 · Cited by 20
Evaluating the Role of Microglial Cells in Clearance of Aβ from Alzheimer’s Brain
Manchikalapudi, A. L., Chilakala, R. R., Kalia, K., & Sunkaria, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00627 · Cited by 18
Zhou, J., Zhang, X., Peng, J., Xie, Y., Du, F., Guo, K., Feng, Y., Zhang, L., Chen, L., & Jiang, Y. Q. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134977 · Cited by 19
Jorge, L., Martins, R., Canário, N., Xavier, A. C., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200840 · Cited by 19
Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old
Pelkmans, W., Legdeur, N., ten Kate, M., Barkhof, F., Yaqub, M. M., Holstege, H. H., van Berckel, B. N. M., Scheltens, P., van der Flier, W. M., Visser, P. J., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51273 · Cited by 17
Aranđelović, J., Santrač, A., Batinić, B., Todorović, L., Stevanović, V., Tiruveedhula, V. V. N. P. B., Sharmin, D., Rashid, F., Stanojević, B., Cook, J. M., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13914 · Cited by 17
Canário, N., Jorge, L., Martins, R., Santana, I. J., & Castelo-Branco, M. S. (2022) · Communications Biology · doi:10.1038/s42003-022-03761-7 · Cited by 21
Tang, D., Fujinaga, M., Hatori, A., Zhang, Y., Yamasaki, T., Xie, L., Mori, W., Kumata, K., Liu, J., Manning, H. C., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.076 · Cited by 17
Microglia activation linking amyloid-β drive tau spatial propagation in Alzheimer's disease
Wang, Q., & Xie, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.951128 · Cited by 20
Translocator Protein (18 kDa) Polymorphism (rs6971) in the Korean Population
Lee, H., Noh, Y., Kim, W., Seo, H., & Park, H.-M. (2022) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2022.21.2.71 · Cited by 17
Contextual fear conditioning regulates synapse-related gene transcription in mouse microglia
Yu, Z., Sakai, M., Fukushima, H., Ono, C., Kikuchi, Y., Koyama, R., Matsui, K., Furuyashiki, T., Kida, S., & Tomita, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.017 · Cited by 16
Peyronneau, M., Kühnast, B., Nguyen, D.-L., Jégo, B., Sayet, G., Caillé, F., Lavisse, S., Gervais, P., Stankoff, B., Sarazin, M., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06286-1 · Cited by 16
Self-citationHooper, C., Barreto, P. D. S., Cantet, C., Cesari, M., Payoux, P., Salabert, A., & Vellas, B. J. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.014 · Cited by 19
Lopez‐Picon, F. R., Keller, T., Bocancea, D. I., Helin, J. S., Krzyczmonik, A., Helin, S., Damont, A., Dollé, F., Rinne, J. O., Haaparanta‐Solin, M., et al. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01646-5 · Cited by 16
Izzy, S., Brown-Whalen, A., Yahya, T., Sarro-Schwartz, A., Jin, G., Chung, J. Y., Lüle, S., Morsett, L. M., Alquraini, A., Wu, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020907 · Cited by 16
Nairuz, T., Heo, J.-C., & Lee, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212156 · Cited by 16
Meyer, P., Savard, M., Poirier, J., Morgan, D., Breitner, J. C. S., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.05.007 · Cited by 15
VEGF controls microglial phagocytic response to amyloid-β
Gea, P. D., Benkeder, S., Bouvet, P., Aimard, M., Chounlamountri, N., Honnorat, J., Do, L.-D., & Meissirel, C. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1264402 · Cited by 19
Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
Katsel, P., & Haroutunian, V. H. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/vharoutunian · Cited by 14
Romero‐Molina, C., Navarro, V., Jiménez, S., Muñoz‐Castro, C., Sanchez-Mico, M. V., Gutiérrez, A., Vitórica, J., & Vizuete, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189734 · Cited by 14
Oxygen Sensing and Signaling in Alzheimer’s Disease: A Breathtaking Story!
Correia, S. C., & Moreira, P. I. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01148-6 · Cited by 14
Snellman, A., Ekblad, L. L., Koivumäki, M., Lindgrén, N., Tuisku, J., Perälä, M., Kallio, L., Lehtonen, R., Saunavaara, V., Saunavaara, J. P., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.826423 · Cited by 15
New PET markers for the diagnosis of dementia
Payoux, P., & Salabert, A. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000489 · Cited by 14
Yousefizadeh, A., Piccioni, G., Saidi, A., Triaca, V., Mango, D., & Nisticò, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106404 · Cited by 15
Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia
Yoo, C. J., Choi, Y., Bok, E., Lin, Y., Cheon, M., Lee, Y., & Kim, J. (2024) · FEBS Journal · doi:10.1111/febs.17150 · Cited by 16
Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease—A Review
Moradi, F., & Mokhtari, T. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70071 · Cited by 14
Neutrophil-to-Lymphocyte Ratio in the Alzheimer’s Disease Continuum
Aprile, D., Marchi, F. D., Menegon, F., Comi, C., & Tondo, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115157 · Cited by 14
Imaging the aging brain: study design and baseline findings of the SENIOR cohort
Haeger, A., Mangin, J., Vignaud, A., Poupon, C., Grigis, A., Boumezbeur, F., Frouin, V., Deverre, J.-R., Sarazin, M., Hertz‐Pannier, L., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00642-1 · Cited by 21
Self-citationPark, K. H. J., & Barrett, T. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200170 · Cited by 12
Effects of the Tibetan medicine Byur dMar Nyer lNga Ril Bu on Alzheimer's disease in mice models
Tsering, J., Chen, Q., Li, H., Han, Y., Wu, J., Yin, H., Hu, J., Su, S., Shi, X., Hu, X., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114724 · Cited by 13
Eysert, F., Kinoshita, P. F., Lagarde, J., Lacas‐Gervais, S., Xicota, L., Dorothée, G., Bottlaender, M., Checler, F., Potier, M., Sarazin, M., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01807-x · Cited by 14
Self-citationChronic benzodiazepine suppresses translocator protein and elevates amyloid β in mice
Tan, S., Metzger, D. B., & Jung, M. E. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.07.005 · Cited by 14
Lagarde, J., Olivieri, P., Tonietto, M., Gervais, P., Comtat, C., Caillé, F., Bottlaender, M., & Sarazin, M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01628-9 · Cited by 17
Self-citationDragović, I. R., Popović, N., Ždralević, M., Radulović, L., Vuković, T., Marzano, F., Tullo, A., & Radunović, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220676 · Cited by 17
Lagarde, J., Olivieri, P., Tonietto, M., Rodrigo, S., Gervais, P., Caillé, F., Moussion, M., Bottlaender, M., & Sarazin, M. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01237-2 · Cited by 14
Self-citationTopalis, V., Voros, C., & Ziaka, M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251361578 · Cited by 14
Pumo, A., & Legeay, S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148817 · Cited by 14
Fairley, L. H., Lai, K. O., Grimm, A., Eckert, A., & Barron, A. M. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.003 · Cited by 14
Microglial responses partially mediate the effect of Aβ on cognition in Alzheimer's disease
Madsen, L. S., Ismail, R., Parbo, P., Kjeldsen, P. L., Schaldemose, J. L., Hansen, K. V., Gottrup, H., Aanerud, J., Eskildsen, S. F., & Brooks, D. J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14298 · Cited by 13
Anton, P. E., Maphis, N. M., Linsenbardt, D. N., & Coleman, L. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-81908-7_10 · Cited by 12
Metadata
- Authors
- Hamelin, L., Lagarde, J., Dorothée, G., Leroy, C., Labit, M., Comley, R. A., de Souza, L. C., Corne, H., Dauphinot, L., Bertoux, M., Dubois, B., Gervais, P., Colliot, O., Potier, M. C., Bottlaender, M., Sarazin, M., & the Clinical IMABio3 team
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre d'Acquisition et de Traitement des Images (FR)
- F. Hoffmann-La Roche AG (CH)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-15
- Volume
- 139
- Issue
- 4
- Pages
- 1252-1264
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2298656843
- Cited by
- 519
- References
- 41
- Citations by year
- 2026: 38 · 2025: 48 · 2024: 71 · 2023: 59 · 2022: 47 · 2021: 47 · 2020: 51 · 2019: 51 · 2018: 57 · 2017: 39 · 2016: 10
- FWCI
- 28.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- European Commission (2007–2013, FP7 2007-2013, FP7/2007, 278850)
- Université Paris Descartes
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, microglial activation, translocator protein (TSPO), [18F]DPA-714, neuroinflammation, prodromal Alzheimer's disease, amyloid imaging, Pittsburgh compound B, clinical progression, amyloidosis, gray matter volume, temporoparietal cortex, frontal cortex, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Female, Fluorine Radioisotopes, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Pyrazoles, Pyrimidines, Cohort Studies, Microglia, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
